Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of intratumoral para-toluenesulfonamide injection for advanced palpable solid tumors
ChiCTR-ONC-12002944Phase 2Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of para-toluenesulfonamide in Nonhematologic neoplasms, sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: Efficacy evaluation and Histologic and pathologic changes. Started Jul 2005; status: completed.
02
Drugs
para-toluenesulfonamide
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on ChiCTR-ONC-12002944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002944.